● TIER 3 — Information onlyGRADE CNootropic / neuro peptides
Dihexa
Angiotensin IV analog. Research verification: Yes (TGA pending). 0 human study record(s) in the FitClinicMD studies database.
GOALS · Cognition
FDA status
Not approved.
Compounding (503A/503B)
Listed by FDA under 'nominated but withdrawn' from Category 2 (i.e., no longer in Category 2, but NOT on the 503A bulks list or Category 1) — (no human exposure data).
DEA
Not controlled.
WADA (sport)
Not listed on 2026 Prohibited List (no matching section found)
Mechanism
HGF/c-Met potentiator.
Human evidence
No qualifying human studies are catalogued for Dihexa in our database. It is listed here for transparency and reference only.
Reference only. This page summarizes publicly available regulatory and research information about Dihexa. It is not a prescription, an endorsement, or an offer to dispense, and regulatory status can change. Clinicians should verify current status before prescribing or compounding.